About 600 reports

China’s demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Diabetes
  • China
  • Industrial Production
  • Labour Force

Key Highlights In 2020 and 2021, with the outbreak of the pandemic, there has been a rise in demand for diabetes devices. This has pushed the companies to partner or collaborate to advance in the diabetes devices market. Mergers and acquisitions (M&A) is the path that manufacturers take to accomplish exponential, rather...

  • Diabetes
  • United States
  • Diabetes Prevalence
  • Drug Approval

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma...

  • Diabetes
  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • World
  • Northern Europe
  • Diabetes Prevalence
  • Health Provider Density

China’s demand for Incretion Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Diabetes
  • Musculoskeletal Disorder
  • China
  • Industrial Production
  • Labour Force

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 13 molecules. Out of which approximately 11 molecules are developed by companies and remaining...

  • Therapy
  • Type 2 Diabetes
  • Diabetes
  • World
  • Medicine Use

Executive Summary The global generic injectables market was valued at USD 134 billion in the year 2021 with the North American region leading the regional market share. Some of the key factors driving the generic injectables market growth are the expiration of branded drug patents, rising approvals for generic injectable...

  • Pharmaceutical
  • Healthcare
  • Diabetes
  • World
  • Diabetes Prevalence
  • Health Expenditure

The global injection pens market is projected to reach USD 53.3 billion by 2026 from USD 37.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Growing prevalence of chronic diseases, increasing number of regulatory approvals, favourable reimbursement and government support, and technological advancements in injection pens tend...

  • Diabetes
  • Therapy
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Diabetes Prevalence

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) pipeline Target constitutes close to 17 molecules. Out...

  • Therapy
  • Pharmaceutical
  • Diabetes
  • Dementia
  • Digestive System Disorder
  • World
  • Northern Europe
  • Diabetes Prevalence
  • Food Consumption

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Diabetes
  • Diagnostics
  • World
  • China
  • Diabetes Prevalence
  • Diabetes Incidence

Diabetes Supplements Market – Scope of Report This report on the global diabetes supplements market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.The report provides revenue of the global diabetes...

  • Diabetes
  • World

Next Generation Diabetes Therapy and Drug Delivery Market By Product (Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas), By Demographic (Adult Population (>14years), Child Population (14years)), By Indication (Type 1 Diabetes, Type 2 Diabetes), By End User (Diagnostic/Clinics, ICUs, Home Healthcare):...

  • Drug Delivery
  • Diabetes
  • Insulin
  • World
  • Disposable Income
  • Diabetes Incidence

Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Drugs In Development, 2021, provides an overview of the Type 1 Diabetes (Metabolic Disorders) pipeline landscape.Type 1...

  • Type 1 Diabetes
  • Endocrine Disease
  • World

Diabetes Therapeutics Market By Product (Injectables, Oral antidiabetic Drugs): Global Opportunity Analysis and Industry Forecast, 2020-2030 The global diabetes therapeutics market was valued at $1,258,936.4 million in 2020, and is projected to reach $3,390,002.1 million by 2030, registering a CAGR of 10.4% from 2021...

  • Diabetes
  • Antidiabetics
  • World
  • APAC
  • Diabetes Prevalence

Type 1 Diabetes - Epidemiology Forecast to 2029 Summary Type 1 Diabetes (T1D), formerly referred to as insulin-dependent diabetes, is a type of diabetes that predominantly develops in children or young adults before the age of 40 years.The condition, therefore, was also referred to as juvenile diabetes. T1D...

  • Type 1 Diabetes
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

Diabetes Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Diabetes Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Diabetes Devices types, applications. Further, Diabetes Devices market...

  • Diabetes
  • World

Diabetes Pen market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Diabetes Pen Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Diabetes Pen types, applications. Further, Diabetes Pen market size is forecast...

  • Diabetes
  • World

Diabetes Injection Pens market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Diabetes Injection Pens Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Diabetes Injection Pens types, applications. Further,...

  • Diabetes
  • World

Diabetes Treatment And Prevention market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Diabetes Treatment And Prevention Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Diabetes Treatment And Prevention...

  • Antidiabetics
  • Diabetes
  • World

The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition.However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which...

  • Insulin Delivery
  • Diabetes
  • Pharmaceutical
  • Diabetes Monitoring
  • World

Combination Anti-diabetes Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Combination Anti-diabetes Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Combination Anti-diabetes Drugs types,...

  • Diabetes
  • World

Oral Anti-diabetes Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Oral Anti-diabetes Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Oral Anti-diabetes Drugs types, applications. Further,...

  • Diabetes
  • World

Free Fatty Acid Receptor 1 - Drugs In Development, 2021 Summary According to the recently published report ’Free Fatty Acid Receptor 1 - Drugs In Development, 2021’; Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) pipeline Target constitutes close to 18 molecules. Out...

  • Pharmaceutical
  • Type 2 Diabetes
  • World
  • Drug Approval
  • Diabetes Prevalence

“Type2 Diabetes Mellitus- Pipeline Insight, 2022,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Type2 Diabetes mellitus pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route...

  • Diabetes
  • World
  • Life Expectancy

Glucokinase - Pipeline Review, H2 2020 Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucokinase...

  • Therapy
  • Type 2 Diabetes
  • Diabetes
  • Drug Development
  • World
  • Diabetes Prevalence
  • Medicine Use

Endoscopy Devices for Obesity, Type II Diabetes and NASH Market by Product (Endoscope, Mechanical Endoscopic Equipment, Visualization and Documentation Systems, Accessories, and Other Endoscopy Equipment), Procedure (Gastric Balloon, Aspiration Therapy, Endoscopic Sleeve Gastroplasty, Gastric Injection, and Lap Band Surgery), and Disease...

  • Endoscopic Device
  • Diabetes
  • Obesity
  • World
  • Overweight Prevalence
  • Drug Approval

Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies...

  • Type 2 Diabetes
  • Pharmaceutical
  • Diabetes
  • Therapy
  • Drug Development
  • Dementia
  • Type 1 Diabetes
  • Biotechnology
  • World
  • Diabetes Prevalence
  • Energy Consumption

The Global Digital Diabetes Management Market size is expected to reach $29.5 billion by 2028, rising at a market growth of 12.0% CAGR during the forecast period. Diabetes is a chronic disease in which the body’s glucose levels rise due to decreased insulin secretion from the pancreas and insulin’s inability to keep blood glucose levels...

  • Antidiabetics
  • Diabetes
  • Diabetes Monitoring
  • Insulin Delivery
  • World
  • Diabetes Prevalence
  • Medical Technology Density

Abstract: - Global Diabetes Drugs Market to Reach $86.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Diabetes Drugs estimated at US$61.5 Billion in the year 2020, is projected to reach a revised size of US$86.8 Billion by 2027, growing at aCAGR of 5% over the period 2020-2027. Injectables, one...

  • Diabetes
  • World
  • China
  • United States

Abstract: - Global Diabetes Injection Pens Market to Reach $11.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Diabetes Injection Pens estimated at US$7.2 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2027, growing at aCAGR of 6.7% over the period 2020-2027....

  • Diabetes
  • World
  • China
  • United States

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Pipeline Review, H2 2020, provides an overview of the Type 1 Diabetes (Metabolic Disorders) pipeline landscape. Type 1 diabetes (T1D) is...

  • Type 1 Diabetes
  • Endocrine Disease
  • World